Fixed Price IPO | ₹6 Cr | Listed at BSE SME | Fri, Dec 13, 2024 - Tue, Dec 17, 2024
Hamps Bio IPO is a fixed price issue of ₹6.22 crores. The issue is entirely a fresh issue of 0.12 crore shares of ₹6.22 crore.
Hamps Bio IPO bidding started from Dec 13, 2024 and ended on Dec 17, 2024. The allotment for Hamps Bio IPO was finalized on Dec 18, 2024. The shares got listed on BSE SME on Dec 20, 2024.
Hamps Bio IPO price is ₹51 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹1,02,000 (2000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (4,000 shares), amounting to ₹2,04,000.
Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Pure Broking Pvt.Ltd..
Refer to Hamps Bio IPO RHP for detailed Information.
IPO Open
Fri, Dec 13, 2024
IPO Close
Tue, Dec 17, 2024
Issue Price
₹51 per share
Market Cap (Pre-IPO)
₹22.22 Cr
| IPO Date | 13 to 17 Dec, 2024 |
| Listed on | Fri, Dec 20, 2024 |
| Face Value | ₹10 per share |
| Issue Price | ₹51 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 12,20,000 shares (agg. up to ₹6 Cr) |
| Reserved for Market Maker | 62,000 shares Pure Broking Pvt.Ltd. (agg. up to ₹0.3162 Cr) |
| Fresh Issue (Ex Market Maker) | 11,58,000 shares (agg. up to ₹6 Cr) |
| Net Offered to Public | 11,58,000 shares (agg. up to ₹6 Cr) |
| Share Holding Pre Issue | 31,36,000 shares |
| Share Holding Post Issue | 43,56,000 shares |
| BSE Script Code | 544312 |
| ISIN | INE0QBD01018 |
Hamps Bio IPO comprises a total issue size of 12,20,000 shares. The net offer to the public is 11,58,000 shares, after excluding 62,000 shares allotted on a firm basis. Of the Net offer 5,78,000 (49.91%) allocated to NII 5,80,000 (50.09%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 5,78,000 | 49.91% | 47.38% |
| Retail Shares Offered | 5,80,000 | 50.09% | 47.54% |
| Firm Reservations | |||
| Market Maker Shares Offered | 62,000 | 5.08% | |
| Total Shares Offered | 12,20,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 2,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹1,02,000 |
| Retail (Max) | 1 | 2,000 | ₹1,02,000 |
| HNI (Min) | 2 | 4,000 | ₹2,04,000 |
Incorporated in 2007, Hamps Bio Limited is engaged in the marketing and distribution of pharmaceutical products like tablets, syrups, capsules, injectables, oil, and nutritional supplements.
The company distributes its products through a network of over 50 distributors and e-commerce platforms, including Amazon (US, Canada, EU), Flipkart, and Jio Mart. Their pharma products are sold in 8 states and union territories, while Freeze-dried and Frozen products reach 6 countries and 22 states and union territories.
The company's business is divided into two segments:
The company offers over 180 products across both segments. As of October 31, 2024, The company had 78 employees.
Competitive Strengths:
| Period Ended | 31 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 6.44 | 5.15 | 3.96 | 3.64 |
| Total Income | 4.36 | 6.50 | 5.58 | 5.34 |
| Profit After Tax | 0.34 | 0.50 | 0.36 | 0.12 |
| NET Worth | 3.71 | 3.37 | 1.36 | 1.01 |
| Reserves and Surplus | 0.57 | 1.41 | -0.14 | -0.49 |
| Total Borrowing | 1.38 | 1.05 | 1.74 | 2.04 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of plant & machinery for FMCG division; | 3.59 |
| 2 | Enhancing the visibility and awareness of our brand; | 0.50 |
| 3 | General corporate purposes | 1.52 |
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 21.14% |
| ROCE | 18.31% |
| Debt/Equity | 0.31 |
| RoNW | 14.84% |
| PAT Margin | 7.73% |
| Price to Book Value | 2.96 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 1.60 | 1.34 |
| P/E (x) | 31.94 | 38.03 |
| Promoter Holding | 100% | 71.99% |
| Market Cap | ₹22.22 Cr. |
The Hamps Bio IPO is subscribed 1,057 times on December 17, 2024 6:20:09 PM (Day 3). The public issue subscribed 1,342.04 times in the retail category, [.] times in the QIB category, and 758.27 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for | Total Application |
|---|---|---|---|---|
| NII* | 758.27 | 5,79,000 | 43,90,36,000 | 34,525 |
| Retail | 1,342.04 | 5,79,000 | 77,70,42,000 | 3,88,521 |
| Total | 1,057 | 11,58,001 | 1,22,40,12,000 | 6,65,592 |
Total Application : 6,65,592
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLM fees (including underwriting,) | 0.32 |
| 2 | Commission / processing fee to Sponsor Bank and Bankers to the Issue. Brokerage and selling commission and bidding charges of the Registered Brokers, RTAs and CDPs | 0.11 |
| 3 | Fees payable to Registrar to the Issue | 0.02 |
| 4 | Fees payable to auditors and other consultants / professionals | 0.03 |
| 5 | Listing Fees and BSE Processing Fees and other regulatory expense | 0.05 |
| 6 | Advertising and Marketing expenses and Printing and Stationery | 0.02 |
| 7 | Fees payable to Legal Advisors to the Issue | 0.01 |
| 8 | Miscellaneous | 0.06 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹51.00 |
| Open | ₹96.90 |
| Low | ₹96.90 |
| High | ₹101.74 |
| Last Trade | ₹101.74 |
Lead Manager Reports
Hamps Bio IPO is a SME IPO of 12,20,000 equity shares of the face value of ₹10 aggregating up to ₹6 Crores. The issue is priced at ₹51 per share. The minimum order quantity is 2000.
The IPO opens on Fri, Dec 13, 2024, and closes on Tue, Dec 17, 2024.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Hamps Bio IPO using UPI as a payment gateway. Zerodha customers can apply in Hamps Bio IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Hamps Bio IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Hamps Bio IPO opens on Fri, Dec 13, 2024 and closes on Tue, Dec 17, 2024.
Hamps Bio IPO lot size is 2000, and the minimum amount required for application is ₹1,02,000.
You can apply in Hamps Bio IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Hamps Bio IPO will be done on Wednesday, December 18, 2024, and the allotted shares will be credited to your demat account by Thu, Dec 19, 2024. Check the Hamps Bio IPO allotment status.
The Hamps Bio IPO listing date is on Fri, Dec 20, 2024.
